We surveyed signature genes in MC3, MC4, and MC5 pro-tumorigenic myeloid cells and TC4 (Tregs) and TC5 (exhausted T cells) to discover highly expressed genes that are shared and may be manipulated to reprogram both innate and adaptive immune cells in GBM. This evidence concerns the gene MC3R and glioblastoma.